trending Market Intelligence /marketintelligence/en/news-insights/trending/Dr1eyRdHXY0u7iqf8IR3BQ2 content esgSubNav
In This List

Windtree Therapeutics to implement reverse stock split

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Windtree Therapeutics to implement reverse stock split

Windtree Therapeutics, Inc. will implement a 1-for-20 reverse stock split of its issued and outstanding common stock.

The company's common stock will begin trading on a split-adjusted basis at the opening of the OTCQB market on Dec. 22, under the symbol WINTD. The stock's symbol will revert to the original WINT after 20 trading days.